
FMC Corporation
NYSE•FMC
CEO: Dr. Pierre R. Brondeau Ph.D.
Sector: Basic Materials
Industry: Agricultural Inputs
Listing Date: 1980-03-17
FMC Corporation, an agricultural sciences company, provides crop protection, plant health, and professional pest and turf management products. It develops, markets, and sells crop protection chemicals that includes insecticides, herbicides, and fungicides; and biologicals, crop nutrition, and seed treatment products, which are used in agriculture to enhance crop yield and quality by controlling a range of insects, weeds, and diseases, as well as in non-agricultural markets for pest control. The company markets its products through its own sales organization and through alliance partners, independent distributors, and sales representatives. It operates in North America, Latin America, Europe, the Middle East, Africa, and Asia. The company was founded in 1883 and is headquartered in Philadelphia, Pennsylvania.
Contact Information
FMC Tower, 2929 Walnut Street Cira Centre South, Philadelphia, PA, 19104, United States
215-299-6000
Market Cap
$1.67B
P/E (TTM)
-3.1
19.4
Dividend Yield
17.4%
52W High
$57.00
52W Low
$12.17
52W Range
Rank35Top 21.9%
5.0
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024
Financial Dashboard
Q3 2025 Data
Revenue
$489.00M-54.10%
4-Quarter Trend
EPS
-$4.52-969.23%
4-Quarter Trend
FCF
-$231.90M-284.78%
4-Quarter Trend
2025 Q3 Earnings Highlights
Key Highlights
Q3 Revenue Hit By India Actions Q3 Revenue was $542.2 M, a 49 percent decrease versus prior year, driven by one-time commercial actions in India.
Significant Net Loss Reported Nine months Net loss attributable to stockholders was $(518.1) M, contrasting sharply with $357.4 M income last year.
Major India Divestiture Charges Recorded $510 M in charges and write-downs in Q3 2025 to prepare India business for sale, including asset impairment.
Cash Flow Turns Negative Nine months cash provided by operations was $(663.3) M, leading to Free Cash Flow of $(788.5) M for the period.
Risk Factors
India Sale Distorts Results Q3 Revenue dropped 49 percent due to $419 M in revenue charges from commercial actions positioning India business for sale.
Negative Operating Cash Usage Cash required by operating activities of continuing operations was $(663.3) M for nine months, indicating significant cash burn.
Increased Debt Levels Total debt increased to $4,542.2 M by September 30, 2025, driven by new borrowings including $750 M Subordinated Notes.
Pending Derivative Litigation Multiple derivative and shareholder derivative lawsuits are pending against officers and directors based on alleged misconduct.
Outlook
2025 Revenue Guidance Issued Expect 2025 revenue excluding India $3.92 B to $4.02 B, representing a 7 percent decline at the midpoint versus 2024.
Quarterly Dividend Policy Reduced Board reduced quarterly dividend to $0.08 per share starting December 2025 to prioritize debt reduction efforts.
Restructuring Completion Expected Project Focus restructuring plan is expected to be complete by end of 2025, targeting cost savings exceeding $225 M run-rate.
Adjusted EBITDA Guidance Set Forecast 2025 Adjusted EBITDA between $830 M and $870 M, a 6 percent midpoint decrease versus 2024 results.
Peer Comparison
Revenue (TTM)
SSL$28.48B
$3.71B
FMC$3.56B
Gross Margin (Latest Quarter)
51.2%
BCPC35.7%
SXT34.3%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| BCPC | $5.09B | 34.4 | 12.1% | 9.4% |
| SSL | $4.10B | 10.1 | 4.5% | 33.6% |
| SXT | $4.09B | 29.2 | 12.4% | 32.2% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-26.4%
Growth Under Pressure
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
50%
Cash Flow Needs Attention
Research & Insights
Next earnings:Feb 3, 2026
EPS:$1.23
|Revenue:-
Reports
All Years
Form 10-Q - Q3 2025
Period End: Sep 30, 2025|Filed: Oct 30, 2025|Revenue: $489.00M-54.1%|EPS: $-4.52-969.2%MissForm 10-Q - Q2 2025
Period End: Jun 30, 2025|Filed: Jul 31, 2025|Revenue: $1.05B+1.2%|EPS: $0.53-77.4%MissForm 10-Q - Q1 2025
Period End: Mar 31, 2025|Filed: May 1, 2025|Revenue: $791.40M-13.8%|EPS: $-0.12+455.6%MissForm 10-K - FY 2024
Period End: Dec 31, 2024|Filed: Feb 28, 2025|Revenue: $4.25B-5.4%|EPS: $2.73-74.0%BeatForm 10-Q - Q3 2024
Period End: Sep 30, 2024|Filed: Oct 30, 2024|Revenue: $1.07B+8.5%|EPS: $0.52-1957.1%MissForm 10-Q - Q2 2024
Period End: Jun 30, 2024|Filed: Aug 1, 2024|Revenue: $1.04B+2.4%|EPS: $2.35+879.2%BeatForm 10-Q - Q1 2024
Period End: Mar 31, 2024|Filed: May 7, 2024|Revenue: $918.00M-31.7%|EPS: $-0.02-101.4%MissForm 10-K - FY 2023
Period End: Dec 31, 2023|Filed: Feb 27, 2024|Revenue: $4.49B-22.7%|EPS: $10.51+80.3%Beat